3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Endocrine
1
Conditions
Colorectal Neoplasms
14
Breast Neoplasms
12
Lung Neoplasms
10
Uterine Cervical Neoplasms
9
Neoplasms
8
Colonic Neoplasms
5
Hematopoietic and Lymphatic System Neoplasm
4
Prostatic Neoplasms
3
Papillomavirus Infections
3
Liver Neoplasms
3
Carcinoma, Hepatocellular
3
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Patient Compliance
2
Carcinoma, Intraductal, Noninfiltrating
2
Tobacco Use
1
Smoking
1
Pyloric Stenosis, Hypertrophic
1
Psychological Well-Being
1
Overweight
1
Obesity
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma
1
Liver Diseases
1
Hypertension
1
Hepatitis C
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Interventions
Nutrition Assessment
4
Bevacizumab
3
Lisinopril
2
Labetalol
2
Hydrochlorothiazide
2
Angiotensin-Converting Enzyme Inhibitors
2
ziprasidone
1
pazopanib
1
ganirelix
1
enzalutamide
1
clevidipine
1
bicalutamide
1
benazepril
1
aliskiren
1
Zolpidem
1
Warfarin
1
Vitamin D
1
Vecuronium Bromide
1
Vancomycin
1
Urine Specimen Collection
1
Tumor Necrosis Factors
1
Tranexamic Acid
1
Tobramycin
1
Thiazides
1
Therapeutics
1
Surveys and Questionnaires
1
Sunitinib
1
Sulindac
1
Standard of Care
1
Spironolactone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hypertension
×
Patient Navigation
×
Clear all
NCT01092078
2015-04-22
MISTER-B
NYU Langone Health
Phase NA
Completed
740 enrolled